Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivid Seats (SEAT) Cash & Equivalents (2019 - 2025)

Vivid Seats has reported Cash & Equivalents over the past 7 years, most recently at $103.3 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $103.3 million for Q4 2025, down 57.77% from a year ago — trailing twelve months through Dec 2025 was $103.3 million (down 57.77% YoY), and the annual figure for FY2025 was $103.3 million, down 57.77%.
  • Cash & Equivalents for Q4 2025 was $103.3 million at Vivid Seats, down from $145.7 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for SEAT hit a ceiling of $489.8 million in Q4 2021 and a floor of $103.3 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $261.0 million (2022), compared with a mean of $267.6 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 84.73% in 2024 and later plummeted 57.77% in 2025.
  • Vivid Seats' Cash & Equivalents stood at $489.8 million in 2021, then tumbled by 48.49% to $252.3 million in 2022, then plummeted by 47.51% to $132.4 million in 2023, then skyrocketed by 84.73% to $244.6 million in 2024, then plummeted by 57.77% to $103.3 million in 2025.
  • The last three reported values for Cash & Equivalents were $103.3 million (Q4 2025), $145.7 million (Q3 2025), and $154.0 million (Q2 2025) per Business Quant data.